Nanobio and Nanomedicine

Manufactures gold colloid particles for use in immuno conjugates.

Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum – from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing – Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world.

BD GeneOhm™ develops rapid nucleic acid based diagnostic solutions.

BIND Biosciences, Inc. is a biopharmaceutical company developing therapeutic targeted nanoparticles.

The company's he Bioral® drug delivery technology encapsulates the selected drug in a nanocrystalline structure termed a "cochleate" cylinder.

Manufactures a nanoparticle-based drug delivery platform.

The company produces BioPixels™, semiconductor-based, nanocrystalline fluorescent markers for cell and intracellular detection and analysis.

Develops amphiphilic self-assembling nanocapsules and planar membranes for drug delivery.

The company's Bioral drug delivery technology encapsulates the selected drug in a nanocrystalline structure termed a 'cochleate' cylinder. All of the components of the cochleate cylinder are naturally occurring substances. It is believed that the cochleate cylinder provides an effective delivery mechanism without forming a chemical bond, or otherwise chemically altering, the selected drug.

As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development BioDot is the leading supplier of system tools for the research, development and commercialization of diagnostic tests. As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development of manufacturing processes for the protein array industry.

Developer of ultra-miniaturized nanoarray technologies. Molecular analysis systems are capable of providing nanometer scale, single molecule resolution. Applications in proteomics, diagnostics, and therapeutics.

Develops printed semiconductor based photonic lab-on-a-chip solutions for the life science market.

The company develops clinical diagnostics systems including molecular biology-based assays.

Dental implant technology with nanoscale coatings.

BioMicro Systems is focused on the development and commercialization of biological research products based on its proprietary microfluidic handling technologies.

Provides a range of advanced instruments, including electrochemical workstations and Nanosensors and Nano-Biosensors.

A bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of native state genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level.

The company's technology is based on the large scale production of nanometric particles known as VLPs (virus like particles). The most advanced application of this technology is the production of viral vector derived vaccines for human and animal health.

Biontex specializes in the field of transfection technology, the delivery of genes or DNA to eukaryotic cells.

BioPAL provides products and methods to measure in vivo organ function and to track compounds-of-interest in in vivo systems. Products developed for neutron activation technology include nanocolloids for labeling, tracking and quantifying cells in in vivo models.

Through its diagnostic program, Biophage is developing a biosensor using an innovative nanotechnology. These nanosensors are based on impedance spectroscopy, an enabling technology that can detect and quantify microbial pathogens in real-time. The unique nanosensors will be built from various proprietary technologies already developed by Biophage (biocapture molecule: phages and antibodies) and by the Biotechnology Research Institute-NRC (signal generation and detection).

Develops nanotechnology drug delivery systems based on novel nanomaterials that provide precise control over location and timing of drug delivery.

The company is developing its proprietary calcium phosphate nanotechnology (CAP) for novel vaccines, including biodefense vaccines for toxins such as anthrax and ricin, and drug delivery systems.

The company has a polymer micro-system technology platform comprising core intellectual property in the areas of polymer multilevel micro- and nano-replication, plastic micro-fluidic chip fabrication and photonics integration, to provide unique products for point-of-use analytical applications.

A life sciences R&D company with a special focus on skin cell biology. The company has established proprietary technologies for nano-liposomal formulation techniques.